Biosens

bSens One

The portable analyzer

In preparation for registration

The analyzer of the bSens platform. It takes the reagent strip, runs the measurement and shows the result.

  • Result: with the bSens.INR strip, the measured INR value. Other tests on the same analyzer are on the roadmap.
  • Intended use: that of bSens.INR, self-testing, in preparation for Anvisa registration.
The bSens One analyzer from five angles: front, diagonal, standing on its side, back and in perspective.
Illustrative image: the label and its symbols do not represent the final product. Product in preparation for the Anvisa registration process.

bSens platform

  • Analyzer: The bSens One analyzer, which takes the strip and runs the measurement.

  • Firmware: The analyzer's software, which reads the signal and calculates INR.

One platform, designed for several tests.

The same analyzer and the same architecture are designed to grow from INR to other tests.

The reagent strip

bSens Strips

Scientific context

What the studies say.

Data from scientific papers and books. They describe the condition, the field and the technology, not bSens products.

  • 85%

    In 2004, glucose biosensors accounted for about 85% of the world market for biosensors, according to a 2010 review. 1

  • Potentiostat

    An electrochemical reader, the potentiostat, controls and measures the voltage and electrical current of a sensor. Advances in electronics have taken this instrument from large, heavy benchtop equipment to portable readers for use where the test is done. 2

  • Commercial success

    Alongside lateral flow pregnancy tests, electrochemical glucose meters are among the few biosensors with worldwide commercial success. They are an example of a reader instrument used to read test strips, designed for a single kind of test. 1,2,3

  • POCT

    In a Cochrane review, point-of-care testing is testing done in a clinic, at home or at another site of care, rather than in a standard reference laboratory. A point-of-care device is a portable monitor used by a healthcare provider or by the patient to obtain a clinical measure. 4

  • Self-testing

    A 2016 Cochrane review describes how, in oral anticoagulation, point-of-care devices allow people to test their own INR at home. The review pooled trials of these portable monitors published from 1989 to 2013. 4

  • Known limits

    Point-of-care INR monitors measure clotting time in fingerstick blood and convert it to the INR equivalent of plasma testing. The 2012 American College of Chest Physicians guideline points to limits in the accuracy and precision of these monitors, which differ more from the plasma method as the INR rises above the therapeutic range. 5

References

  1. 1.Yoo EH, Lee SY. Glucose biosensors: an overview of use in clinical practice. Sensors (Basel). 2010;10:4558-4576. doi:10.3390/s100504558
  2. 2.Ainla A, Mousavi MPS, Tsaloglou MN, et al. Open-Source Potentiostat for Wireless Electrochemical Detection with Smartphones. Anal Chem. 2018;90:6240-6246. doi:10.1021/acs.analchem.8b00850
  3. 3.Bhalla N, Jolly P, Formisano N, Estrela P. Introduction to biosensors. Essays Biochem. 2016;60:1-8. doi:10.1042/EBC20150001
  4. 4.Heneghan CJ, Garcia-Alamino JM, Spencer EA, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev. 2016;7:CD003839. doi:10.1002/14651858.CD003839.pub3
  5. 5.Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy. Chest. 2012;141(2 Suppl):e44S-e88S. doi:10.1378/chest.11-2292

Frequently asked questions

Do I need internet?
The analyzer is designed to measure without internet and to sync with bSens Cloud, which is in development, when there is a network.

Contact

Results at the Point of Care

Get in touch to learn about the bSens system.

Please do not send health information by e-mail. Biosens does not interpret test results or guide treatment.

E-mail

contact@biosens.tech

Address

Av. Theodomiro Porto da Fonseca 3101, Building 3, Room 1, 93022-715, São Leopoldo, RS, Brazil